Millipore Sigma Vibrant Logo

69871 pET-29a(+) DNA - Novagen

69871
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
69871-3
Récupération des données relatives à la disponibilité...
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Flacon en verre 10 μg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      Demander le prix
      Description
      OverviewThe pET-29a-c(+) vectors carry an N-terminal S•Tag™/thrombin configuration plus an optional C-terminal His•Tag® sequence. Note that the sequence is numbered by the pBR322 convention, so the T7 expression region is reversed on the vector map (TB076).

      The pET Vectors are supplied as purified plasmid DNA (10 µg). Each order of pET DNA also includes an Induction Control strain (supplied as a glycerol stock). Please contact technical service if you need additional information.




      This product is sold for internal research use only. Any commercial use of this product, its components, and/or any derivatives thereof (including but not limited to proteins produced using the product or its components) (together and hereinafter the 'EMD Product') requires signature of a written commercial use agreement with EMD Millipore Corporation or its successor-in-interest. Commercial use shall include but not be limited to: (1) use of the EMD Product to manufacture products for sale to third parties; (2) use of the EMD Product to provide services, information, or data to third parties in exchange for consideration; (3) use of the EMD Product for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the EMD Product, whether or not such EMD Product is resold for research use. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of the EMD Product. Please direct any questions on these use restrictions to: licensing@milliporesigma.com.
      This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
      Catalogue Number69871
      Brand Family Novagen®
      References
      Product Information
      Quality LevelMQ100
      Applications
      Biological Information
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      69871-3 04055977258752

      Documentation

      pET-29a(+) DNA - Novagen Certificats d'analyse

      TitreNuméro de lot
      69871

      Citations

      Titre
    • Vaillancourt, K., et al. 2008. Applied and Enviornmental Microbiology 74, 1264.
    • Grillo, C., et al. 2007. Journal of Biological Chemistry 282, 10299.
    • Kulikowicz, T., and Shapiro, T.A., 2006. Journal of Biological Chemistry 281, 3048.
    • Beernink, P.T., et al. 2005. Journal of Biological Chemistry 280, 30206.
    • Guazzaroni, M., et al. 2005. Journal of Biological Chemistry 280, 20887.
    • Lara, M.V., et al. 2005. Plant and Cell Physiology 46, 997.
    • Lin P., and Lin-Chao, S., 2005. Proceedings of the National Academy of Sciences (USA) 102, 16590.
    • Lovering, A.L., et al. 2005. Journal of Biological Chemistry 280, 2105.
    • Nagaike, T., et al. 2005 Journal of Biological Chemistry 280, 19721.
    • Rho, S.B., et al. 2005. Journal of Biological Chemistry 280, 34003.
    • Rider, S.D., et al. 2005. Journal of Biological Chemistry 280, 31460.
    • Rancour, D.M., et al. 2004. Journal of Biological Chemistry 279, 54264.
    • Gaynutdinov, T.I., et al. 2003.Protein Engineering 16, 771.
    • Chazalet, V., et al. 2001. Journal of Bacteriology 183, 7067.
    • Jia, Y., et al. 2000. European Molecular Biology Organization Journal 19, 4004.
    • Ma, Z., et al. 1999. Journal of Biological Chemistry 274, 9607.
    • Protocoles Utilisateur

      Titre
      TB053 Academic and Non-profit Laboratory Assurance Letter
      TB055 pET System Manual

      Carte des vecteurs

      Titre
      TB076VM pET-29a-c(+) Vector Map

      Produits & Applications associés

      Related Products

      Catégories

      Life Science Research > Genomic Analysis > Transfection and Protein Expression > Bacterial Expression > Bacterial Expression Vectors